# Remission Clinic in Proteinuric Chronic Nephropathies

> **NCT02721342** · — · UNKNOWN · sponsor: **Mario Negri Institute for Pharmacological Research** · enrollment: 1500 (estimated)

## Conditions studied

- Chronic Kidney Disease

## Interventions

- **DRUG:** Ramipril, Irbesartan and Atorvastin

## Key facts

- **NCT ID:** NCT02721342
- **Lead sponsor:** Mario Negri Institute for Pharmacological Research
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2009-06
- **Primary completion:** 2022-11
- **Final completion:** 2022-11
- **Target enrollment:** 1500 (ESTIMATED)
- **Last updated:** 2022-02-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02721342

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02721342, "Remission Clinic in Proteinuric Chronic Nephropathies". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT02721342. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*